Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Norse Atlantic ASA: New share capital registered

Arendal, 2 February 2024: Reference is made to the stock exchange notice by Norse Atlantic ASA (the "Company") on 25 January 2024 regarding the final results of subsequent offering and allocation of new shares in the Company (the "Subsequent Offering"). The share capital increase pertaining to the issuance of the shares in the Subsequent Offering has now been registered with the Norwegian Register of Business Enterprises: Share capital: NOK 642,619,200 Total number of shares: 128,523,840 Nominal value per share: NOK 5 For further information, please contact: Investors: CFO,

#24-09 Unit issue in Coegin Pharma AB

The board of Coegin Pharma AB (the “Company”) has decided on a unit issue with preferential rights for the Company’s existing shareholders subject to approval from an extra general meeting, to be held on February 5, 2024. The last day of trading in the Company’s shares including the right to receive unit rights is February 5, 2024. The first day of trading in the Company’s shares excluding the right to receive unit rights is February 6, 2024. The record date is February 7, 2024. The shareholders of the Company will receive seven (7) unit rights for each ten (10) shares held per the

Invitation to a Press Conference on Bittium Corporation’s Financial Statement Bulletin 2023

Bittium CorporationPress Release Invitation to a Press Conference on Bittium Corporation’s Financial Statement Bulletin 2023 Bittium Corporation’s Press Release on February 2, 2024, at 3.00 pm (CET+1) Bittium Corporation’s Financial Statement Bulletin 2023 will be published on Friday, February 9, 2024, at 8.00 am (CET+1). The release will be available on company’s website www.bittium.com immediately after the publication. Bittium will hold a webcast for media, analysts and institutional investors on Friday, February 9, 2024, at 9.00 am (CET+1). The webcast will be held in

First US clinical cases successfully conducted with EndoDrill GI

The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), the developer of the world's first market-cleared motorized endoscopic core biopsy instrument, announces that the first US clinical procedures with EndoDrill[®] GI have successfully been performed by Dr Antonio Mendoza Ladd and his team at UC Davis Health, Sacramento, California. BiBB received 510(k) clearance from the US FDA for EndoDrill[®] GI in 2023 and clinical marketing activities will continue in the US.BiBB’s CEO Fredrik Lindblad and founder Dr Charles Walther were present when Dr Antonio Mendoza Ladd,

poLight ASA – New customer confirms release of two new barcode scanner products using TLens®

Horten, 2 February 2024: poLight ASA (OSE: PLT) today announced that Action Prowave Technology Co. Ltd. has confirmed it is using TLens® autofocus solution in the company’s two latest barcode scanners for industrial and logistic warehouse applications, named AW300DP and AW550 respectively. A purchase order worth approximately NOK 200,000 has been received to cover the initial mass production demand. “This will be the 11[th] barcode product to use our unique TLens® divided between six companies. This market is strategically important for the company. Although it will take time to build

Changes in Solteq Plc’s Executive Team

Stock Exchange BulletinChanges board/management/ auditorsFebruary 2, 2024, at 2:15 p.m.The composition of the Executive Team of Solteq Plc changes as of February 2, 2024. With the change, Kari Lehtosalo, the company’s CFO and member of the Executive Team since 2019, will step down from his position by mutual agreement. The Board of Directors of Solteq Plc has appointed LL.M. Mikko Sairanen (b. 1985) as the company’s new CFO. He will also continue in his role as the company’s General Counsel. "I want to thank Kari for the shared years during which he has steered the company's

Fiven ASA publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

Fiven ASA ("Fiven") has issued a senior secured sustainability-linked floating rate bond loan of EUR 110,000,000, within a total framework amount of EUR 170,000,000, on the Nordic bond market. The bonds carry a floating interest rate of EURIBOR 3m + 6.70 per cent. per annum and matures 11 December 2026. Fiven has applied for listing of the bonds on the Corporate Bond list at Nasdaq Stockholm. The bonds will be admitted to trading at Nasdaq Stockholm as soon as possible.   In connection with this, Fiven Company has prepared a prospectus. The prospectus has been approved by the

Year-end report January – December 2023

· Rental income increased 18 per cent to SEK 4,818 million (4,073). · Profit from property management increased 2 per cent to SEK 2,345 million (2,309). · Changes in the value of properties amounted to SEK -5,287 million (589). · Changes in the value of financial instruments amounted to SEK -225 million (251). · Loss after tax for the year amounted to SEK -2,721 million (2,563). · The market value of the properties amounted to SEK 82,624 million (84,879). · During the year, SEK 2,825 million (3,809) was invested in the existing property portfolio. · During the year, 8

Eevia Health Plc received a 112 KSEK / 10 KEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 10 KEUR sales order from a US company for Feno-Myrtillus 25 organic, an organically certified bilberry extract.The customer is a medium-sized US brand holder with distribution throughout North America. The sales value to Eevia of this new order is kEUR 10 and the product is in stock. The product is Eevia’s branded ingredient Feno-Myrtillus® 25 Organic, which is a highly concentrated and organically certified bilberry extract with 25% anthocyanins. “It is the first order from this customer. Although the order is small, we are a

UPM-Kymmene Corporation: Managers’ Transactions (Ehrnrooth)

UPM-Kymmene Corporation                Managers’ Transactions                2 February 2024 at 14:00 EET UPM-Kymmene Corporation: Managers’ Transactions (Ehrnrooth) UPM-Kymmene Corporation has on 2 February 2024 received the following notification:____________________________________________Person subject to the notification requirementName: Henrik EhrnroothPosition: Chair of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64Notification type: INITIAL NOTIFICATION____________________________________________Transaction date: 2024-02-02Venue: NASDAQ

Dolphin Drilling – further part payments from GHL received

Oslo, 2 February 2024 Dolphin Drilling AS (Dolphin Drilling, OSE: DDRIL) announces part payment received from General Hydrocarbons Limited (GHL) related to remaining past due payments. Reference is made to the Dolphin Drilling Q3 financial report from November 28 2023, where we informed of GHL past due payments representing net USD 17.3 million. Dolphin Drilling received today USD 3 million that brings the total collected since the date of Q3 2023 reporting to USD 5.5 million. ENDS For further information, please contact: Ingolf Gillesdal, Corporate Finance and Investor

Neuroendocrine prostate cancer could be restored to a state that responds to treatment

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells. A recent study by the University of Eastern Finland found that this protein, DPYSL5, is expressed in neuroendocrine prostate cancer. Prostate cancer is the most common cancer in men, and the second most common cause of cancer death in Western countries. The growth of prostate cancer often depends on androgens, and the effect of androgens is sought to be reduced by drug therapy, especially in metastatic prostate cancer.

Report from the extraordinary general meeting in Speqta AB (publ) on 2 February 2024

At the extraordinary general meeting in Speqta AB (publ), reg. no. 556710-8757 (the “Company”) on 2 February 2024, the following resolutions, among others, were adopted. For more detailed information on the content of the resolutions, please refer to the notice of the extraordinary general meeting that has previously been published and is available on the Company's website, www.speqta.com. Election of new board member It was resolved in accordance with major shareholders' proposal to dismiss Lisa Gunnarsson at her own request and to elect Fredrik Lindros as new board member of

Hunter Group ASA - Extraordinary General Meeting held on 2 February 2024

Oslo, 2 February 2024 The Extraordinary General Meeting ("EGM") in Hunter Group ASA (the "Company") took place today on 2 February 2024 at 10:00 hours CET. All resolutions were passed in accordance with the proposals set out in the notice for the EGM, including: - Item 4: Approval of private placement of up to NOK 124m - Item 5: Approval of private placement of up to NOK 10m - Item 6: Approval of private placement of up to NOK 25m - Item 7: Approval of authorization to the Board to increase the share capital - Item 8: Election board of directors The minutes from the EGM

Invitation to press- and audio conference regarding Skanska’s Year-end report 2023 on February 9

The report will be presented by Anders Danielsson, Skanska’s President and CEO, and Magnus Persson, CFO, at a press- and audio conference at 10:00 am CET at Skanska’s head office at Warfvinges väg 25 in Stockholm. The press conference will be webcasted live at www.skanska.com/investors, where it also will be posted shortly afterwards. Participate in the audio conference, with the possibility to ask questions. Preferred connection, for best audio quality, please join the call from your phone via the HD Audio web link here: HD Audio link 

Year End Report 2023 - Ayima Group AB

Highlights  4th Quarter: Oct - Dec 2023 · Revenue amounted to 35.1 MSEK (39.1), a decrease of 10% from the corresponding period in 2022 · Gross Profit amounted to 13.8 MSEK (16.9), a decrease of 18% from the corresponding period in 2022  · Operating costs amounted to 13.6 MSEK (19.5), a reduction of 31% from the corresponding period last year · A positive EBITDA result of 0.3 MSEK (-2.6) an improvement of 111% compared to the corresponding period in 2022  · Net Profit after tax for the period was -1.6 MSEK (-1.1) Full Year: Jan - Dec 2023 · Revenue amounted to

XMReality AB engages Carnegie Investment Bank as new Certified Adviser

XMReality AB (publ) today announced a change of Certified Adviser from Redeye AB to Carnegie Investment Bank AB (publ).XMReality has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will take over as Certified Adviser on February 9, 2024. Until then, Redeye AB will continue to act as Certified Adviser to the company. The information was submitted for publication on February 2, 2024, at 12.00 CET.

Enersense’s Shareholders’ Nomination Board’s proposals to the 2024 Annual General Meeting

Enersense International PlcStock exchange release, 2 February 2024 at 12:30 p.m.Enersense International Plc’s Shareholders’ Nomination Board has submitted the following proposals to the company’s Board of Directors for the Annual General Meeting 2024 planned for 4 April 2024: Proposal for the number of members in the Board of Directors and the composition of the Board of Directors The Shareholders’ Nomination Board proposes to the Annual General Meeting that the Board of Directors is composed of eigth (8) members. The Shareholders’ Nomination Board proposes that, for the term of

Expanded collaboration with Raptive contributes to M.O.B.A. Networks growth

The strategic partnership with Raptive regarding ad sales and ad tech has been implemented across all M.O.B.A. Networks community websites. During the third quarter of 2023, a new and significantly improved advertising agreement with Raptive was signed, a logical development in light of the successful collaboration regarding our subsidiary Magic Find's community websites. Intensive implementation work began in the fall of 2023 and was completed at the beginning of 2024. “The expanded collaboration that was recently fully implemented has quickly met our high expectations,” says Peter

Karolinska's Annual Report 2023 sums up another strong year for the hospital

More patients cared for, high quality and satisfied patients. Karolinska University Hospital can sum up a strong 2023.The increase in the number of patients treated at Karolinska University Hospital continues. A total of 334,486 patients received care at the hospital in 2023, an increase of 3 percent compared to the previous year. In 2023, the hospital delivered 6.5 percent more care to Region Stockholm, compared to the region's order. Patient-reported outcome measures, PROMs, are used in most clinics, and are a way to take advantage of the patient's experience of results and function

Eevia Health Plc receives a 289 KSEK / 25 KEUR sales order for a Lingonberry extract product

Eevia Health Plc (”Eevia” or ”The Company”) has received a 25 KEUR sales order for a Lingonberry extract from a Finnish beauty brand.The end customer is a leading Finnish manufacturer and brand owner of cosmetics, who markets and sells high-end cosmetic products in Europe, Asia, and North America. The company is known for its relentless focus on sustainable development practices and natural arctic product lines. The sales value of this order is c. 25 kEUR, and the product is a lingonberry extract standardized on key polyphenols made with a custom-made specialized production protocol and

Publishing of Stockmann’s Financial Statements Bulletin 2023

STOCKMANN plc, Press release 2.2.2024 at 12:00 EET Publishing of Stockmann’s Financial Statements Bulletin 2023 Stockmann plc will publish its Financial Statements Bulletin 2023 on Friday 9 February 2024 at 8:30 EET. A media and analyst briefing will be held in English the same day at 10:00 EET as a live webcast that can be followed via this link.  The recording and presentation material will be available on the company's website  after the event. Further information:Stockmann Media DeskMon–Fri

DOF Group ASA – Contract award

DOF is very pleased to announce a Substantial Contract with an international oil company for the PSV Skandi Kvitsøy. The vessel will work in Australian waters and further strengthen the DOF Group’s presence in Australia. Commencement will be Q1 2024 with 2-year firm and 2 years options. For further information, please contact:Martin Lundberg, SVP Finance and Investor Relations DOF Group ASAPhone: + +47 916 21 057E-mail: martin.lundberg@dof.com  DOF Group defines a Substantial Contract as a contract with value between NOK 250 million to NOK 500 million.

Wärtsilä’s Hanna-Maria Heikkinen named as Investor Relations Director of the year 2023

Wärtsilä Corporation, News, 2 February 2024 at 12 AM EETHanna-Maria Heikkinen, Vice President, Investor Relations at Wärtsilä has been named Investor Relations Director of the year 2023 in Finland by The Finnish Foundation for Share Promotion. The jury of leading investor influencers paid particular attention to the reach and clarity of Wärtsilä’s investor communication on the company's website and social media channels. One contributor was the increased number of shareholders. Ms Heikkinen was recognized as an exceptionally active investor relations leader who has developed her profession

There are no items matching the current filter
There are no more items matching the current filter
Back to top